De novo expression of fetal ED-A+ fibronectin and B+ tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
De novo expression of fetal ED-A+ fibronectin and B+ tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection
Authors
Keywords
ED-A<sup>+</sup> fibronectin, B<sup>+</sup> tenascin-C, Cardiac rejection, Inflammation, Targeted therapy
Journal
JOURNAL OF MOLECULAR HISTOLOGY
Volume 45, Issue 5, Pages 519-532
Publisher
Springer Nature
Online
2014-05-02
DOI
10.1007/s10735-014-9573-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer
- (2013) Teresa Hemmerle et al. INTERNATIONAL JOURNAL OF CANCER
- Selective imaging of chronic cardiac rejection using a human antibody specific to the alternatively spliced EDA domain of fibronectin
- (2013) Marcus Franz et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Phase 0 Microdosing PET Study Using the Human Mini Antibody F16SIP in Head and Neck Cancer Patients
- (2013) D. A. Heuveling et al. JOURNAL OF NUCLEAR MEDICINE
- Antibody-Based Delivery of Interleukin-2 to Neovasculature Has Potent Activity Against Acute Myeloid Leukemia
- (2013) K. L. Gutbrodt et al. Science Translational Medicine
- Immunocytokines: a novel class of potent armed antibodies
- (2012) Nadine Pasche et al. DRUG DISCOVERY TODAY
- Antibody–drug conjugates: Basic concepts, examples and future perspectives
- (2012) Giulio Casi et al. JOURNAL OF CONTROLLED RELEASE
- The Registry of the International Society for Heart and Lung Transplantation: 29th Official Adult Heart Transplant Report—2012
- (2012) Josef Stehlik et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Radioimmunotherapy with Radretumab in Patients with Relapsed Hematologic Malignancies
- (2012) P. A. Erba et al. JOURNAL OF NUCLEAR MEDICINE
- Isolated limb perfusion with the tumor-targeting human monoclonal antibody-cytokine fusion protein L19-TNF plus melphalan and mild hyperthermia in patients with locally advanced extremity melanoma
- (2012) Francesco Papadia et al. JOURNAL OF SURGICAL ONCOLOGY
- Comparative analysis of oncofetal fibronectin and tenascin-C expression in right atrial auricular and left ventricular human cardiac tissue from patients with coronary artery disease and aortic valve stenosis
- (2011) Anja Baldinger et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Polymorphic variants in tenascin-C (TNC) are associated with atherosclerosis and coronary artery disease
- (2011) Mollie A. Minear et al. HUMAN GENETICS
- Chronic cardiac allograft rejection: critical role of ED-A+fibronectin and implications for targeted therapy strategies
- (2011) Marcus Franz et al. JOURNAL OF PATHOLOGY
- Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis
- (2011) Adam J Booth et al. JOURNAL OF PATHOLOGY
- Comparative in vivo analysis of the atherosclerotic plaque targeting properties of eight human monoclonal antibodies
- (2010) Michael Fiechter et al. ATHEROSCLEROSIS
- Characteristics of Chronic Rejection in Heart Transplantation:
- (2010) Jun-ichi Suzuki et al. CIRCULATION JOURNAL
- Extra cellular matrix remodelling after heterotopic rat heart transplantation: gene expression profiling and involvement of ED-A+ fibronectin, alpha-smooth muscle actin and B+ tenascin-C in chronic cardiac allograft rejection
- (2010) Marcus Franz et al. HISTOCHEMISTRY AND CELL BIOLOGY
- The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients
- (2010) Maria Rosa Costanzo et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Expression of extra domain A containing fibronectin in chronic cardiac allograft rejection
- (2010) Marcus Franz et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Changes in extra cellular matrix remodelling and re-expression of fibronectin and tenascin-C splicing variants in human myocardial tissue of the right atrial auricle: implications for a targeted therapy of cardiovascular diseases using human SIP format antibodies
- (2010) Marcus Franz et al. JOURNAL OF MOLECULAR HISTOLOGY
- Therapeutic benefits of human mesenchymal stem cells derived from bone marrow after global cerebral ischemia
- (2009) Wei Zheng et al. BRAIN RESEARCH
- Serum levels of large tenascin-C variants, matrix metalloproteinase-9, and tissue inhibitors of matrix metalloproteinases in concentric versus eccentric left ventricular hypertrophy
- (2009) Marcus Franz et al. EUROPEAN JOURNAL OF HEART FAILURE
- Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis
- (2009) Kathrin Schwager et al. ARTHRITIS RESEARCH & THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started